Plasma levels of matrix metalloproteinase-9 in children with chronic spontaneous urticaria
![Thumbnail](/xmlui/bitstream/handle/11446/1092/Plasma%20Levels%20of%20Matrix%20Metalloproteinase-9%20in%20Children%20With%20Chronic%20Spontaneous%20Urticaria..pdf.jpg?sequence=4&isAllowed=y)
Göster/ Aç
Erişim
info:eu-repo/semantics/openAccessTarih
2016Yazar
Dilek, FatihÖzçeker, Deniz
Özkaya, Emin
Tamay, Zeynep
Yazıcı, Mebrure
Kesgin, Sıddıka
Güler, Nermin
Üst veri
Tüm öğe kaydını gösterKünye
Dilek F, Ozceker D, Ozkaya E, Tamay Z, Yazici M, Kesgin S, Kocyigit A, Guler N. Plasma Levels of Matrix Metalloproteinase-9 in Children With Chronic Spontaneous Urticaria. Allergy Asthma Immunol Res. 2016; 8(6): 522-526. doi: 10.4168/aair.2016.8.6.522Özet
Purpose: Chronic spontaneous urticaria (CSU) is a disease that is primarily seen in adults and is comparatively rare in children. Consequently, only a few studies have focused on the pathogenesis of the disease in children. This study investigated the possible role of metalloproteinase-9 (MMP-9) in the pathogenesis of CSU in children.
Methods: The study group was composed of 54 children with CSU; 34 healthy children comprised the control group. The demographic and clinical features of the study group were extensively evaluated, and laboratory assessments were also performed. An enzyme-linked immunosorbent assay was used to evaluate levels of plasma MMP-9. Disease activity was quantified using the urticaria activity score (UAS).